Find a Doctor

Robert J. Arceci, MD, PhD

Phoenix Children's Medical Group Division Chief - Hematology/Oncology; Co-Director of the Ronald A. Matricaria Institute of Molecular Medicine At Phoenix Children’s Hospital, Hematology & Oncology

Office: Phoenix Childrens Medical Group - Hematology / Oncology
Address: 1919 E Thomas Rd, Phoenix, AZ 85016-7710
Phone: (602) 933-0920
Fax: (602) 933-0276
Professional Affiliations: Pediatric Oncology Group, the Children’s Cancer Group and the Children’s Oncology Group, including Chairperson for the Myeloid Leukemia Committee and Vice-Chair of the Biology and Therapeutics Translational Committee
Academic Affiliations: Professor of Pediatrics - University of Arizona College of Medicine,
Translational Genomics Research Institute
Degree/Certifications: MD, PhD
Board Certifications: Pediatric Hematology-Oncology, Pediatrics
Medical School/Education: University of Rochester Rochester, NY (M.D. and PhD in Molecular and Developmental Biology)
Residency: Boston Childrens Hospital Boston, MA
Fellowship: (Pediatric Hematology/Oncology) Boston Childrens Hospital, Dana Farber Cancer Institute, Harvard Medical School Boston, MA
Dr. Arceci completed his undergraduate studies at Trinity College, received his Ph.D. and M.D. from the University of Rochester, and then completed his Residency in Pediatrics and Fellowship in Pediatric Hematology/Oncology at The Children’s Hospital, Boston and Harvard Medical School. Following faculty appointments at Harvard Medical School, the Dana Farber Cancer Institute and Boston Children’s Hospital, he became Director of Pediatric Hematology/Oncology at Children’s Hospital Medical Center in Cincinnati. In 2000, Dr. Arceci became Director and King Fahd Professor of Pediatric Oncology and Professor of Oncology and Pediatrics at the Johns Hopkins University School of Medicine. He currently serves as Director, Children’s Center for Cancer and Blood Disorders Hematology/Oncology at Phoenix Children’s Hospital and the University of Arizona College of Medicine, Phoenix as well as Co-Director of the Ron Matricaria Institute of Molecular Medicine.

Dr. Arceci is a member of numerous scientific and medical societies, advisory committees and review boards, and has been the recipient of several prestigious honors and awards. He is the author of a large number of published scholarly works and serves as a reviewer for several distinguished journals. He is considered an international authority in many challenging areas of clinical pediatric oncology including the diagnosis and treatment of Leukemia and Langerhans Cell Histiocytosis. He has served on a variety of committees in the Pediatric Oncology Group, the Children’s Cancer Group and the Children’s Oncology Group, including Chairperson for the Myeloid Leukemia Committee and Vice-Chair of the Biology and Therapeutics Translational Committee. Dr. Arceci is Editor-in-Chief of Pediatric Blood and Cancer and has previously served as Editor-in-Chief of the Journal of Pediatric Hematology/Oncology and Associate editor of the Journal of Pediatrics. He is the editor of several textbooks, the most recent, Pediatric Hematology, along with co-editors, Ian Hann and Owen Smith, Targeted Therapy in Pediatric Cancer with co-editor, Peter Houghton, and served as editor of the oncology section of the most recent Rudolf’s Pediatrics. He is a co-editor of a textbook in preparation titled, Cancer Genomics. He has been a Leukemia/Lymphoma Society translational researcher. He continues to be actively involved in defining optimal health care models as well as educational initiatives and has received several teaching awards and given the While Coat Lecture at the 2009 Johns Hopkins ceremony. He was the originator of the internationally acclaimed movie on childhood cancer, A Lion in the House, filmed by documentary filmmakers Steven Bognar and Julia Reichert.

A physician/scientist who has concentrated his work on basic and translational research in pediatric hematology and oncology, Dr. Arceci's focus continues on discovery and implementation of basic science to improve the comprehensive care for children and adolescents with cancer. He has been particularly involved in the development of novel therapeutic targets and immunotherapies to improve outcomes while reducing adverse side effects in patients with cancer. A large part of his focus is to bring together teams of multidisciplinary groups of investigators to develop scientifically robust and interactive environments for molecularly based, individualized treatment.
Research/Special Interests: Basic and translational research in pediatric hematology and oncology;
Publications: Editor-in-Chief of Pediatric Blood and Cancer and has previously served as Editor-in-Chief of the Journal of Pediatric Hematology/Oncology and Associate editor of the Journal of Pediatrics. He is the editor of several textbooks, the most recent, Pediatri